FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2284156619> ?p ?o ?g. }

• W2284156619 endingPage "1804" @default.
• W2284156619 startingPage "1795" @default.
• W2284156619 abstract "Permeability-glycoprotein (P-glycoprotein, P-gp), an efflux transporter at the human blood-brain barrier (BBB), is a significant obstacle to central nervous system (CNS) delivery of P-gp substrate drugs. Using positron emission tomography imaging, we investigated P-gp modulation at the human BBB by an approved P-gp inhibitor, quinidine, or the P-gp inducer, rifampin. Cerebral blood flow (CBF) and BBB P-gp activity were respectively measured by administration of (15)O-water followed by (11)C-verapamil. In a crossover design, healthy volunteers received quinidine and 11-29 days of rifampin treatment during different study periods. CBF and P-gp activity was measured in the absence (control; prior to quinidine treatment) and presence of P-gp modulation. At clinically relevant quinidine plasma concentrations, P-gp inhibition resulted in a 60% increase in (11)C-radioactivity distribution across the human BBB as measured by the brain extraction ratio (ER) of (11)C-radioactivity. Furthermore, the magnitude of BBB P-gp inhibition by quinidine was successfully predicted by a combination of in vitro and macaque data, but not by rat data. Although our findings demonstrated that quinidine did not completely inhibit P-gp at the human BBB, it has the potential to produce clinically significant CNS drug interactions with P-gp substrate drugs that exhibit a narrow therapeutic window and are significantly excluded from the brain by P-gp. Rifampin treatment induced systemic CYP3A metabolism of (11)C-verapamil; however, it reduced the ER by 6%. Therefore, we conclude that rifampin, at its usual clinical dose, cannot be used to induce P-gp at the human BBB to a clinically meaningful extent and is unlikely to cause inadvertent BBB-inductive drug interactions." @default.
• W2284156619 created "2016-06-24" @default.
• W2284156619 creator A5001271137 @default.
• W2284156619 creator A5002814609 @default.
• W2284156619 creator A5020600016 @default.
• W2284156619 creator A5025579054 @default.
• W2284156619 creator A5029867597 @default.
• W2284156619 creator A5059664612 @default.
• W2284156619 creator A5063481044 @default.
• W2284156619 creator A5072312981 @default.
• W2284156619 creator A5086275985 @default.
• W2284156619 creator A5090348690 @default.
• W2284156619 date "2015-09-09" @default.
• W2284156619 modified "2023-09-28" @default.
• W2284156619 title "Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study" @default.
• W2284156619 cites W1759188384 @default.
• W2284156619 cites W1807250678 @default.
• W2284156619 cites W1922401242 @default.
• W2284156619 cites W1970199708 @default.
• W2284156619 cites W1971129489 @default.
• W2284156619 cites W1979946819 @default.
• W2284156619 cites W1981625417 @default.
• W2284156619 cites W1987820290 @default.
• W2284156619 cites W1989588317 @default.
• W2284156619 cites W1992553889 @default.
• W2284156619 cites W1992635559 @default.
• W2284156619 cites W1998502315 @default.
• W2284156619 cites W2009169076 @default.
• W2284156619 cites W2010633862 @default.
• W2284156619 cites W2021275669 @default.
• W2284156619 cites W2030021013 @default.
• W2284156619 cites W2034416686 @default.
• W2284156619 cites W2046268338 @default.
• W2284156619 cites W2049517140 @default.
• W2284156619 cites W2049869379 @default.
• W2284156619 cites W2051018226 @default.
• W2284156619 cites W2051263617 @default.
• W2284156619 cites W2057592154 @default.
• W2284156619 cites W2059841300 @default.
• W2284156619 cites W2069416682 @default.
• W2284156619 cites W2070587942 @default.
• W2284156619 cites W2078231944 @default.
• W2284156619 cites W2083673453 @default.
• W2284156619 cites W2083791591 @default.
• W2284156619 cites W2090945850 @default.
• W2284156619 cites W2108486409 @default.
• W2284156619 cites W2110980033 @default.
• W2284156619 cites W2112001901 @default.
• W2284156619 cites W2119085762 @default.
• W2284156619 cites W2124596819 @default.
• W2284156619 cites W2129122317 @default.
• W2284156619 cites W2130580676 @default.
• W2284156619 cites W2130945756 @default.
• W2284156619 cites W2133475198 @default.
• W2284156619 cites W2136487679 @default.
• W2284156619 cites W2139880444 @default.
• W2284156619 cites W2140293712 @default.
• W2284156619 cites W2140975778 @default.
• W2284156619 cites W2149385083 @default.
• W2284156619 cites W2157393167 @default.
• W2284156619 cites W2163209521 @default.
• W2284156619 cites W2166015457 @default.
• W2284156619 cites W2167527439 @default.
• W2284156619 cites W2168239564 @default.
• W2284156619 cites W2169526301 @default.
• W2284156619 cites W2326717879 @default.
• W2284156619 cites W4251824657 @default.
• W2284156619 doi "https://doi.org/10.1124/dmd.114.058685" @default.
• W2284156619 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4613948" @default.
• W2284156619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26354948" @default.
• W2284156619 hasPublicationYear "2015" @default.
• W2284156619 type Work @default.
• W2284156619 sameAs 2284156619 @default.
• W2284156619 citedByCount "37" @default.
• W2284156619 countsByYear W22841566192016 @default.
• W2284156619 countsByYear W22841566192017 @default.
• W2284156619 countsByYear W22841566192018 @default.
• W2284156619 countsByYear W22841566192019 @default.
• W2284156619 countsByYear W22841566192020 @default.
• W2284156619 countsByYear W22841566192021 @default.
• W2284156619 countsByYear W22841566192022 @default.
• W2284156619 crossrefType "journal-article" @default.
• W2284156619 hasAuthorship W2284156619A5001271137 @default.
• W2284156619 hasAuthorship W2284156619A5002814609 @default.
• W2284156619 hasAuthorship W2284156619A5020600016 @default.
• W2284156619 hasAuthorship W2284156619A5025579054 @default.
• W2284156619 hasAuthorship W2284156619A5029867597 @default.
• W2284156619 hasAuthorship W2284156619A5059664612 @default.
• W2284156619 hasAuthorship W2284156619A5063481044 @default.
• W2284156619 hasAuthorship W2284156619A5072312981 @default.
• W2284156619 hasAuthorship W2284156619A5086275985 @default.
• W2284156619 hasAuthorship W2284156619A5090348690 @default.
• W2284156619 hasBestOaLocation W22841566191 @default.
• W2284156619 hasConcept C126322002 @default.
• W2284156619 hasConcept C133936738 @default.
• W2284156619 hasConcept C134018914 @default.
• W2284156619 hasConcept C185592680 @default.
• W2284156619 hasConcept C2777022698 @default.

• next